Literature DB >> 33479578

Diagnosis, prevention, and treatment of cardiovascular diseases in people with type 2 diabetes and prediabetes: a consensus statement jointly from the Japanese Circulation Society and the Japan Diabetes Society.

Eiichi Araki1, Atsushi Tanaka2, Nobuya Inagaki3, Hiroshi Ito4, Kohjiro Ueki5, Toyoaki Murohara6, Kenjiro Imai7, Masataka Sata8, Takehiro Sugiyama7, Hideki Ishii9, Shunsuke Yamane3, Takashi Kadowaki10, Issei Komuro11, Koichi Node2.   

Abstract

Entities:  

Year:  2020        PMID： 33479578      PMCID： PMC7790968          DOI： 10.1007/s13340-020-00471-5

Source DB:  PubMed          Journal:  Diabetol Int        ISSN： 2190-1678


× No keyword cloud information.
  284 in total

Review 1.  Lessons from contemporary trials of cardiovascular prevention and rehabilitation: A systematic review and meta-analysis.

Authors:  Gijs van Halewijn; Jaap Deckers; Hung Yong Tay; Ron van Domburg; Kornelia Kotseva; David Wood
Journal:  Int J Cardiol       Date:  2016-12-23       Impact factor: 4.164

2.  Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness.

Authors:  Inês Falcão-Pires; Nazha Hamdani; Attila Borbély; Cristina Gavina; Casper G Schalkwijk; Jolanda van der Velden; Loek van Heerebeek; Ger J M Stienen; Hans W M Niessen; Adelino F Leite-Moreira; Walter J Paulus
Journal:  Circulation       Date:  2011-08-15       Impact factor: 29.690

3.  Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents.

Authors:  Ippei Shimizu; Tohru Minamino; Haruhiro Toko; Sho Okada; Hiroyuki Ikeda; Noritaka Yasuda; Kaoru Tateno; Junji Moriya; Masataka Yokoyama; Aika Nojima; Gou Young Koh; Hiroshi Akazawa; Ichiro Shiojima; C Ronald Kahn; E Dale Abel; Issei Komuro
Journal:  J Clin Invest       Date:  2010-04-19       Impact factor: 14.808

Review 4.  Body Mass Index, Abdominal Fatness, and Heart Failure Incidence and Mortality: A Systematic Review and Dose-Response Meta-Analysis of Prospective Studies.

Authors:  Dagfinn Aune; Abhijit Sen; Teresa Norat; Imre Janszky; Pål Romundstad; Serena Tonstad; Lars J Vatten
Journal:  Circulation       Date:  2016-01-08       Impact factor: 29.690

5.  Effects of intensive glycaemic control on ischaemic heart disease: analysis of data from the randomised, controlled ACCORD trial.

Authors:  Hertzel C Gerstein; Michael E Miller; Faramarz Ismail-Beigi; Joe Largay; Charlotte McDonald; Heather A Lochnan; Gillian L Booth
Journal:  Lancet       Date:  2014-07-31       Impact factor: 79.321

6.  Effect of aerobic exercise intensity on glycemic control in type 2 diabetes: a meta-analysis of head-to-head randomized trials.

Authors:  Yilina Liubaoerjijin; Tasuku Terada; Kevin Fletcher; Normand G Boulé
Journal:  Acta Diabetol       Date:  2016-06-02       Impact factor: 4.280

7.  European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).

Authors:  Joep Perk; Guy De Backer; Helmut Gohlke; Ian Graham; Zeljko Reiner; Monique Verschuren; Christian Albus; Pascale Benlian; Gudrun Boysen; Renata Cifkova; Christi Deaton; Shah Ebrahim; Miles Fisher; Giuseppe Germano; Richard Hobbs; Arno Hoes; Sehnaz Karadeniz; Alessandro Mezzani; Eva Prescott; Lars Ryden; Martin Scherer; Mikko Syvänne; Wilma J M Scholte op Reimer; Christiaan Vrints; David Wood; Jose Luis Zamorano; Faiez Zannad
Journal:  Eur Heart J       Date:  2012-05-03       Impact factor: 29.983

Review 8.  Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.

Authors:  Bianca Hemmingsen; Søren S Lund; Christian Gluud; Allan Vaag; Thomas Almdal; Christina Hemmingsen; Jørn Wetterslev
Journal:  BMJ       Date:  2011-11-24

9.  A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF).

Authors:  John J V McMurray; David L DeMets; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Anna M Langkilde; Felipe A Martinez; Olof Bengtsson; Piotr Ponikowski; Marc S Sabatine; Mikaela Sjöstrand; Scott D Solomon
Journal:  Eur J Heart Fail       Date:  2019-03-21       Impact factor: 15.534

Review 10.  Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.

Authors:  Birgit Fullerton; Klaus Jeitler; Mirjam Seitz; Karl Horvath; Andrea Berghold; Andrea Siebenhofer
Journal:  Cochrane Database Syst Rev       Date:  2014-02-14
View more
  2 in total

Review 1.  Recent Updates to Clinical Practice Guidelines for Diabetes Mellitus.

Authors:  Jin Yu; Seung-Hwan Lee; Mee Kyoung Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2022-02-28

2.  Comparison of the clinical effect of empagliflozin on glycemic and non-glycemic parameters in Japanese patients with type 2 diabetes and cardiovascular disease treated with or without baseline metformin.

Authors:  Atsushi Tanaka; Michio Shimabukuro; Hiroki Teragawa; Yosuke Okada; Toshinari Takamura; Isao Taguchi; Shigeru Toyoda; Hirofumi Tomiyama; Shinichiro Ueda; Yukihito Higashi; Koichi Node
Journal:  Cardiovasc Diabetol       Date:  2021-07-31       Impact factor: 9.951
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.